ATE369565T1 - Verwendung eines viruses, der ein bindungsteil exprimiert, zur messung von analyten in einer probe - Google Patents

Verwendung eines viruses, der ein bindungsteil exprimiert, zur messung von analyten in einer probe

Info

Publication number
ATE369565T1
ATE369565T1 AT04716274T AT04716274T ATE369565T1 AT E369565 T1 ATE369565 T1 AT E369565T1 AT 04716274 T AT04716274 T AT 04716274T AT 04716274 T AT04716274 T AT 04716274T AT E369565 T1 ATE369565 T1 AT E369565T1
Authority
AT
Austria
Prior art keywords
expresses
sample
viruse
binding mobile
measure analytes
Prior art date
Application number
AT04716274T
Other languages
English (en)
Inventor
David James Squirrell
Martin Lee
Carl Mayers
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE369565T1 publication Critical patent/ATE369565T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00Labels used in chemical analysis of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
AT04716274T 2003-03-04 2004-03-02 Verwendung eines viruses, der ein bindungsteil exprimiert, zur messung von analyten in einer probe ATE369565T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0304832.9A GB0304832D0 (en) 2003-03-04 2003-03-04 Assay method

Publications (1)

Publication Number Publication Date
ATE369565T1 true ATE369565T1 (de) 2007-08-15

Family

ID=9954019

Family Applications (3)

Application Number Title Priority Date Filing Date
AT07011811T ATE430316T1 (de) 2003-03-04 2004-03-02 Verwendung eines virus, das ein bindungsteil exprimiert, zur messung von analyten in einer probe
AT09158701T ATE515701T1 (de) 2003-03-04 2004-03-02 Verwendung eines bindungsteil exprimierenden virus zur messung von analyten in einer probe
AT04716274T ATE369565T1 (de) 2003-03-04 2004-03-02 Verwendung eines viruses, der ein bindungsteil exprimiert, zur messung von analyten in einer probe

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT07011811T ATE430316T1 (de) 2003-03-04 2004-03-02 Verwendung eines virus, das ein bindungsteil exprimiert, zur messung von analyten in einer probe
AT09158701T ATE515701T1 (de) 2003-03-04 2004-03-02 Verwendung eines bindungsteil exprimierenden virus zur messung von analyten in einer probe

Country Status (12)

Country Link
US (1) US20060216694A1 (de)
EP (3) EP1879030B1 (de)
JP (1) JP5038712B2 (de)
CN (1) CN100504394C (de)
AT (3) ATE430316T1 (de)
AU (1) AU2004217724B2 (de)
CA (1) CA2518036A1 (de)
DE (2) DE602004008043T2 (de)
ES (1) ES2291857T3 (de)
GB (1) GB0304832D0 (de)
TW (1) TW200502399A (de)
WO (1) WO2004079369A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1885853A2 (de) * 2005-05-27 2008-02-13 Guild Associates, Inc. Biologisches detektionssystem und -verfahren
US9568431B2 (en) 2012-04-16 2017-02-14 Access Medical Systems, Ltd. Luminescent immunoassays for quantitating analytes having a wide concentration range
CN107278270B (zh) * 2014-09-07 2021-06-01 思兰克斯有限公司 用于细胞分离的微流体方法和盒
JP7347849B2 (ja) * 2018-04-19 2023-09-20 ファースト ライト ダイアグノスティクス, インコーポレイテッド 標的の検出

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365368B1 (en) * 1985-05-10 2002-04-02 Igen International, Inc. Rapid method for the detection and quantification of microbes in water
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IE64040B1 (en) * 1989-06-15 1995-06-28 Akzo Nv Method for determining nucleic acid
ES2044784B1 (es) * 1992-06-12 1994-09-01 Inia Procedimiento para la deteccion e identificacion de patogenos virales y subvirales.
ZA97248B (en) * 1996-01-18 1997-07-18 Rohm & Haas Method for identifying and quantifying polymers utilizing immunoassay techniques
US6190856B1 (en) * 1996-05-22 2001-02-20 The Johns Hopkins University Methods of detection utilizing modified bacteriophage
US5922537A (en) * 1996-11-08 1999-07-13 N.o slashed.AB Immunoassay, Inc. Nanoparticles biosensor
IT1291913B1 (it) * 1997-05-22 1999-01-21 Angeletti P Ist Richerche Bio Metodo che prevede l'uso di batteriofagi per la rivelazione della presenza di molecole di interesse in campioni biologici
GB9725197D0 (en) 1997-11-29 1998-01-28 Secr Defence Detection system
GB9725237D0 (en) 1997-11-29 1998-01-28 Secr Defence Amplification system
GB9803382D0 (en) 1998-02-19 1998-04-15 Secr Defence Detection system
WO1999063348A1 (en) * 1998-06-04 1999-12-09 Microsens Biophage Limited Analytical method using multiple virus labelling
GB9812768D0 (en) 1998-06-13 1998-08-12 Zeneca Ltd Methods
US6927024B2 (en) * 1998-11-30 2005-08-09 Genentech, Inc. PCR assay
CN1352567A (zh) * 1999-02-25 2002-06-05 新眼界诊断公司 预防性和治疗性治疗链球菌感染的方法
AU778776B2 (en) * 1999-04-14 2004-12-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The High sensitivity phage display biomolecule detection
GB9928787D0 (en) * 1999-12-03 2000-02-02 Medical Res Council Direct screening method
EP1122542A1 (de) * 2000-02-01 2001-08-08 Anda Biologicals S.A. Verfahren zum schnellen Nachweis von ganzen Mikroorganismen über Rückhaltemembranen mit Hilfe von caotropischen Mitteln
WO2004027028A2 (en) * 2002-09-18 2004-04-01 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture

Also Published As

Publication number Publication date
EP2105741A2 (de) 2009-09-30
EP2105741B1 (de) 2011-07-06
TW200502399A (en) 2005-01-16
CN100504394C (zh) 2009-06-24
AU2004217724A1 (en) 2004-09-16
EP1879030A2 (de) 2008-01-16
ATE430316T1 (de) 2009-05-15
WO2004079369A1 (en) 2004-09-16
US20060216694A1 (en) 2006-09-28
EP1879030A3 (de) 2008-03-19
ATE515701T1 (de) 2011-07-15
GB0304832D0 (en) 2003-04-09
HK1091540A1 (zh) 2007-01-19
EP1599731B1 (de) 2007-08-08
EP1879030B1 (de) 2009-04-29
DE602004008043T2 (de) 2008-04-30
ES2291857T3 (es) 2008-03-01
EP1599731A1 (de) 2005-11-30
EP2105741A3 (de) 2010-02-17
JP5038712B2 (ja) 2012-10-03
DE602004020941D1 (de) 2009-06-10
CN1784603A (zh) 2006-06-07
JP2006520592A (ja) 2006-09-14
DE602004008043D1 (de) 2007-09-20
CA2518036A1 (en) 2004-09-16
AU2004217724B2 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
CY1126069T1 (el) Προσδιορισμος για αντισωματα ιου jc
EP3432002A8 (de) Blutgerinnungsanalysator, blutgerinnungsanalyseverfahren und computerprogramm
Zhang et al. Timing readout in paper device for quantitative point-of-use hemin/G-quadruplex DNAzyme-based bioassays
WO2006126008A3 (en) Improved immunoassay methods
EA200600893A1 (ru) Определение гематокрита и концентрации аналита
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
ATE467835T1 (de) Membran-basierendes verfahren unter verwendung von zeitaufgelösten fluoreszenzmessungen
WO2004113912A8 (en) System and method for determining a temperature during analysis of biological fluid
MXPA02010106A (es) Determinacion de suficiencia de volumen de muestra en dispositivos biosensores.
DE60024448D1 (de) System zur elektrochemischen quantitativen analyse von analyten in einer festphase
DE60319230D1 (de) Selbst-kalibrierendes system für magnetisches bindungs-verfahren
ATE437237T1 (de) Verfahren zur messung von hochdichtem lipoproteincholesterol
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE502005005132D1 (de) Verfahren zur erhöhung des dynamischen messbereichs von auf spezifischen bindereaktionen basierenden, insbesondere immunologischen testelementen
WO2005040759A3 (en) Apparatus and methods for detecting target analyte
DE602005014386D1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
DE69736336D1 (de) Verfahren zur messung von blutersatzstoffen
ATE525656T1 (de) Proteinmessverfahren
DE60318435D1 (de) Universeller biosensor und verfahren zur verwendung
ATE555385T1 (de) N1,n12-diacetylspermin als tumormarker
ATE330225T1 (de) Verfahren und testkit zum nachweis von analyten in einer probe
ATE409314T1 (de) Verfahren zur beurteilung rheumatoider arthritis durch messen von anti-ccp und serumamyloid a
ATE369565T1 (de) Verwendung eines viruses, der ein bindungsteil exprimiert, zur messung von analyten in einer probe
ATE550655T1 (de) Verfahren zur bestimmung eines analyten in einer körperflüssigkeit
JP2008070366A5 (de)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties